Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for allegedly misleading investors regarding its business practices and compliance with regulations [1][2]. Allegations - The lawsuit claims that SelectQuote and its executives failed to disclose that they steered Medicare beneficiaries to insurance plans that paid the highest commissions rather than those best suited for customers [8] - It is alleged that SelectQuote did not provide unbiased Medicare Advantage comparisons as claimed [8] - The company is accused of accepting illegal kickbacks to favor certain insurers, which limited competition [8] - SelectQuote is said to have been non-compliant with laws, regulations, and contracts, exposing it to regulatory and legal risks, including under the False Claims Act [8] - Positive statements made by the company regarding its business and prospects were misleading and lacked a reasonable basis [8] Impact on Investors - Following the announcement by the U.S. Department of Justice on May 1, 2025, SelectQuote's stock price fell by 19.2%, decreasing by $0.61 to close at $2.56 per share [3].
Shareholders who lost money in shares of SelectQuote, Inc. (NYSE: SLQT)Should Contact Wolf Haldenstein Immediately.